日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A novel mitochondrial quality regulation gene signature for anticipating prognosis, TME, and therapeutic response in LUAD by multi-omics analysis and experimental verification

通过多组学分析和实验验证,发现一种新型线粒体质量调控基因特征可用于预测肺腺癌的预后、肿瘤微环境和治疗反应。

Zeng, Lijun; Wu, Sixuan; Li, Zhimin; Tang, Yuanbin; Tan, Yeru; Liang, Renji; Li, Yuehua

Unveiling diagnostic biomarkers and therapeutic targets in lung adenocarcinoma using bioinformatics and experimental validation

利用生物信息学和实验验证揭示肺腺癌的诊断生物标志物和治疗靶点

Wu, Sixuan; Tang, Yuanbin; Pan, Qihong; Zheng, Yaqin; Tan, Yeru; Pan, Junfan; Li, Yuehua

TBL2 Promotes Tumorigenesis via PRMT5/WDR77-Mediated AKT Activation in Breast Cancer.

TBL2 通过 PRMT5/WDR77 介导的 AKT 激活促进乳腺癌的肿瘤发生

Lu Xiuqing, Zhang Chao, Zhu Lewei, Wang Sifen, Zeng Lijun, Zhong Wenjing, Wu Xuxia, Yuan Qi, Tang Hailin, Cui Shien, Tan Yeru, Li Yuehua, Wei Weidong

Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer

诱导铁死亡有可能克服乳腺癌的治疗耐药性。

Qi, Xiaowen; Wan, Zhixing; Jiang, Baohong; Ouyang, Yuhan; Feng, Wenjie; Zhu, Hongbo; Tan, Yeru; He, Rongfang; Xie, Liming; Li, Yuehua

Circ0038632 modulates MiR-186/DNMT3A axis to promote proliferation and metastasis in osteosarcoma

Circ0038632通过调节miR-186/DNMT3A轴促进骨肉瘤的增殖和转移

Tan, Xinyu; Zeng, Canjun; Li, Haomiao; Tan, Yeru; Zhu, Hongbo